Nashville, TNNCT07735533Now EnrollingIRB Ready

Lymphoma, B Cell Clinical Trial in Nashville, TN

Access cutting-edge lymphoma, b cell treatment through this phase 1/2 clinical trial at a research site in Nashville. Study-provided care at no cost to qualified participants.

Sponsored by Umoja Biopharma

Quick Self-Assessment

See if you qualify for this Nashville location

Preparing your pre-screening questions…

Expert Care in Nashville

Access lymphoma, b cell specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related lymphoma, b cell treatment provided free

Apply for This Nashville Location

Check if you qualify for this lymphoma, b cell clinical trial in Nashville, TN

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Nashville

    Convenient for TN residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Nashville site if eligible
  4. 4Begin participation

About This Lymphoma, B Cell Study in Nashville

This study is a Phase 1/2 dose-finding and dose-confirmation study to evaluate the safety and antitumor activity of UB-VV400. The study will enroll patients with relapsed/refractory B-cell malignancies, including large B-cell lymphoma (LBCL).

Sponsor: Umoja Biopharma

Who Can Participate

Inclusion Criteria

18 years or older
Provides voluntary written informed consent
Relapsed or refractory large B-cell lymphoma (LBCL)
Measurable disease according to Lugano 2014 criteria
Confirmed CD22 expression
No serious concomitant diseases or active/uncontrolled infections
Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1
Adequate organ function

Exclusion Criteria

Women who are pregnant or breastfeeding
Current isolated central nervous system (CNS) involvement
Prior allogeneic bone marrow transplant, gene therapy, or adoptive cell transfer (except tumor-infiltrating lymphocytes, CAR-NK cells, T-cell receptor \[TCR\] fusion constructs, TCR T cells, and CAR T cells)
History of or active human immunodeficiency virus (HIV)
Active or chronic hepatitis B, or active hepatitis C
Systemic immunodeficiency diseases, except for well-controlled Type I diabetes or thyroid disease
Ongoing CNS disease that would preclude neurologic assessment
Uncontrolled angina or other acute heart disease
Currently receiving treatment in another interventional clinical trial.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Nashville?

Yes, this clinical trial (NCT07735533) has an active research site in Nashville, TN that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Lymphoma, B Cell Treatment Options in Nashville, TN

If you're searching for lymphoma, b cell treatment options in Nashville, TN, this clinical trial (NCT07735533) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Nashville research site is actively enrolling participants for this phase 1/2 clinical trial. You'll receive care from experienced lymphoma, b cell specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all lymphoma, b cell clinical trials near you to find additional studies recruiting in your area.

More Lymphoma Trials in Nashville, TN

See all lymphoma clinical trials recruiting in Nashville — not just this study.

Browse Lymphoma Trials in Nashville →

Ready to Join in Nashville?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Nashville, TN